Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
LegitScript-supported marketing pathways
For more information, contact us or schedule an appointment online
SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERR, ERR, ERR), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an exercise mimetic. It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance
Topol noted that "there is no evidence from randomized trials in humans that any of these peptides provide the benefits that are advocated," and the same evidence gap applies in reverse to long-horizon harms
Reconstituted peptides left at room temperature degrade rapidly through accelerated hydrolysis, oxidation, and bacterial growth
